{"id":4751,"date":"2017-01-07T20:31:26","date_gmt":"2017-01-08T01:31:26","guid":{"rendered":"http:\/\/www.newlonkong.com\/English\/?p=4751"},"modified":"2017-01-07T20:31:26","modified_gmt":"2017-01-08T01:31:26","slug":"bluebird-bio-inc-blue","status":"publish","type":"post","link":"https:\/\/www.newlonkong.com\/English\/bluebird-bio-inc-blue\/","title":{"rendered":"bluebird bio, Inc. (BLUE)"},"content":{"rendered":"<p><a href=\"http:\/\/www.newlonkong.com\/English\/markets\/new-york\/list-of-stocks-us\/bluebird-bio-inc-blue\/\">bluebird bio, Inc. (BLUE)<\/a> is a biotech company, and it keeps losing money. &nbsp;Bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>bluebird bio, Inc. (BLUE) is a biotech company, and it keeps losing money. &nbsp;Bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[853,818],"tags":[875,874],"class_list":["post-4751","post","type-post","status-publish","format-standard","hentry","category-bio","category-to-short","tag-blue","tag-bluebird"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/comments?post=4751"}],"version-history":[{"count":1,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4751\/revisions"}],"predecessor-version":[{"id":4755,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/posts\/4751\/revisions\/4755"}],"wp:attachment":[{"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/media?parent=4751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/categories?post=4751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newlonkong.com\/English\/wp-json\/wp\/v2\/tags?post=4751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}